i’SUPPLY Platform Secures $2.5 Million Funding to Support Pharmaceutical Distribution Technology

Pioneering Model in Pharmaceutical Distribution Technology

Since its launch, i’SUPPLY has distinguished itself by providing innovative solutions in the field of pharmaceutical distribution. The platform has achieved an annual transaction volume of nearly 1 billion Egyptian pounds and has issued over 1 million purchase orders annually. Its integrated network includes more than 10,000 pharmacies and collaborates with over 200 distribution companies, offering more than 10,000 products.

Significant Financial Performance Growth

i’SUPPLY has demonstrated remarkable growth in transactions and revenues, increasing fivefold during the period from the beginning of 2024 until the end of May, compared to the same period in 2023. This growth reflects the company’s strategic efficiency and its ability to meet the increasing market demands.

Leadership Statements

Ibrahim Imam, CEO and co-founder of i’SUPPLY, stated: “This funding round will support our expansion plans and significantly increase funding opportunities for small and medium-sized pharmacies. We aim to obtain a license for financing small and medium-sized enterprises from the Egyptian Financial Regulatory Authority this year, to meet the growing market need for funding.”

Abdelrahman Mansour, Executive Director at Egypt Ventures, commented: “We are excited to partner with i’SUPPLY and support its expansion plans. We are confident that the innovative, fully digital platform will continue to develop the industry by enhancing efficiency and addressing gaps in the pharmaceutical supply chain.”

Malek Sultan, co-founder of DisrupTech Ventures, affirmed: “We are proud to continue our support for i’SUPPLY, as it contributes to improving the relationship between pharmacies and distributors. Financing pharmacies is a necessary and urgent offering in the Egyptian market, and we support their efforts to obtain the financial license.”

Operational Efficiency and Profitability

i’SUPPLY achieved profitability in less than 18 months since its launch, reflecting its operational efficiency and effective capital management. The financial license will enhance the company’s capabilities to use the new funding to support its expansion plans and fund small and medium-sized pharmacies. Additionally, it will provide the latest and most advanced technologies to all stakeholders in the pharmaceutical supply chain, including manufacturers, distributors, pharmacies, and private and government hospitals, while expanding fintech services.

i’SUPPLY continues to achieve significant success in the field of pharmaceutical distribution technology thanks to its innovative strategies and extensive network of pharmacies and distribution companies. With the new funding and expansion plans, the company is poised to maintain its leadership in improving the efficiency of the pharmaceutical supply chain and supporting small and medium-sized pharmacies in the Egyptian market.

Read Also: Stake Secures $14 Million Series A Funding to Expand Real Estate Investment Platform